Maintaining Competitiveness through New Product Development and Improvements
First written in FY2016. 22 of 26 entries say "Restated". Latest entry: FY2026.
- FY2026AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥186 million.」
In addition to Nihon Dia Valve, newly consolidated subsidiary Asahi Sunac also conducted R&D, and R&D expenses increased from ¥152 million in the previous fiscal year to ¥186 million. - FY2025AdvancedAnnual report
「As a manufacturer focused mainly on diaphragm, ball and butterfly valves, the company has sought to maintain its competitiveness through new product development and improvements. Total R&D expenses for the current consolidated fiscal year were ¥152 million.」
The company continued developing and improving new products through Nihon Dia Valve, and R&D expenses increased from ¥142 million in the previous fiscal year to ¥152 million. - FY2024-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥63 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
The company recognized ¥63 million in R&D expenses and continued to explain that there had been no material changes in its R&D activities. - FY2024-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥32 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenses were ¥32 million, and the company continued to explain that there had been no material changes in its R&D activities. - FY2023AdvancedAnnual report
「As a manufacturer focused mainly on diaphragm, ball and butterfly valves, the company has sought to maintain its competitiveness through new product development and improvements. Total R&D expenses for the current consolidated fiscal year were ¥142 million.」
The company continued developing and improving new products through Nihon Dia Valve, and R&D expenses increased from ¥109 million in the previous fiscal year to ¥142 million. - FY2023-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥60 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
The company recognized ¥60 million in R&D expenses and continued to explain that there had been no material changes in its R&D activities. - FY2022RestatedAnnual report
「As a manufacturer focused mainly on diaphragm, ball and butterfly valves, the company has sought to maintain its competitiveness through new product development and improvements. Total R&D expenses for the current consolidated fiscal year were ¥109 million.」
The company continued its policy of developing and improving new products through Nihon Dia Valve, and R&D expenses were ¥109 million. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥56 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
The company recognized ¥56 million in R&D expenses and continued to explain that there had been no material changes in its R&D activities. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥89 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
The company recognized ¥89 million in R&D expenses and continued to explain that there had been no material changes in its R&D activities. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥56 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
The company recognized ¥56 million in R&D expenses and continued to explain that there had been no material changes in its R&D activities. - FY2020RestatedAnnual report
「As a manufacturer focused mainly on diaphragm, ball and butterfly valves, the company has sought to maintain its competitiveness through new product development and improvements. Total R&D expenses for the current consolidated fiscal year were ¥124 million.」
The company continued developing and improving new products through Nihon Dia Valve, and R&D expenses were ¥124 million. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥91 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenses were ¥91 million for the cumulative third quarter, and the company continued to explain that there had been no material changes in its R&D activities. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥64 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenses were ¥64 million, and the company continued to explain that there had been no material changes in its R&D activities. - FY2020-Q1RestatedAnnual report
「Total research and development expenses for the three months ended Q1 were ¥27 million. There were no significant changes in the status of the group’s research and development activities during the three months ended Q1.」
R&D expenses were ¥27 million, and the company continued to explain that there had been no material changes in its R&D activities. - FY2019RestatedAnnual report
「As a manufacturer focused primarily on diaphragm, ball and butterfly valves, the company works to maintain its competitiveness through new product development and enhancements. Total research and development expenses for the fiscal year were ¥127 million.」
The company continued to maintain its competitiveness through new product development and enhancements, with full-year research and development expenses reaching ¥127 million. - FY2019-Q3RestatedAnnual report
「Total research and development expenses for the nine months ended Q3 were ¥95 million. There were no significant changes in the status of the group’s research and development activities during the nine months ended Q3.」
Research and development expenses reached ¥95 million for the nine months ended Q3, and the company continued to state that there were no significant changes in the status of its research and development activities. - FY2019-Q2RestatedAnnual report
「Total research and development expenses for the six months ended Q2 were ¥62 million. There were no significant changes in the status of the group’s research and development activities during the six months ended Q2.」
Research and development expenses reached ¥62 million for the first half, and the company continued to state that there were no significant changes in the status of its research and development activities. - FY2019-Q1RestatedAnnual report
「Total research and development expenses for the three months ended Q1 were ¥28 million. There were no significant changes in the status of the group’s research and development activities during the three months ended Q1.」
Research and development expenses were ¥28 million, and the company continued to describe its policy and status of having no significant changes in its research and development activities. - FY2018-Q3RestatedAnnual report
「Total research and development expenses for the nine months ended Q3 were ¥96 million. There were no significant changes in the status of the group’s research and development activities during the nine months ended Q3.」
Research and development expenses reached ¥96 million for the nine months ended Q3, while the company stated that there were no significant changes in the status of its research and development activities. - FY2018-Q2RestatedAnnual report
「Total research and development expenses for the six months ended Q2 were ¥65 million. There were no significant changes in the status of the group’s research and development activities during the six months ended Q2.」
The company stated that research and development expenses were ¥65 million, while there were no significant changes in the status of its research and development activities. - FY2018-Q1RestatedAnnual report
「Total research and development expenses for the three months ended Q1 were ¥31 million. There were no significant changes in the status of the group’s research and development activities during the three months ended Q1.」
The company stated that research and development expenses were ¥31 million, while there were no significant changes in the status of its research and development activities. - FY2017RestatedAnnual report
「As a manufacturer focused primarily on diaphragm, ball and butterfly valves, the company works to maintain its competitiveness through new product development and enhancements. Total research and development expenses for the fiscal year were ¥129 million.」
The company continued to maintain its competitiveness through new product development and enhancements, with research and development expenses reaching ¥129 million. - FY2017-Q3RestatedAnnual report
「Total research and development expenses for the nine months ended Q3 were ¥97 million. There were no significant changes in the status of the group’s research and development activities during the nine months ended Q3.」
Research and development expenses reached ¥97 million for the nine months ended Q3, while the company reiterated that there were no significant changes in its research and development activities. - FY2017-Q2RestatedAnnual report
「Total research and development expenses for the six months ended Q2 were ¥67 million. There were no significant changes in the status of the group’s research and development activities during the six months ended Q2.」
Research and development expenses were ¥67 million, and the company reiterated that there were no significant changes in its research and development activities. - FY2017-Q1RestatedAnnual report
「Total research and development expenses for the three months ended Q1 were ¥28 million. There were no significant changes in the status of the group’s research and development activities during the three months ended Q1.」
The company disclosed total research and development expenses of ¥28 million for the first quarter while stating that there were no significant changes in its research and development activities. - FY2016First statedAnnual report
「As a manufacturer focused primarily on diaphragm, ball and butterfly valves, the company works to maintain its competitiveness through new product development and enhancements. Total research and development expenses for the fiscal year were ¥123 million.」
日本ダイヤバルブ was responsible for research and development, with total research and development expenses of ¥123 million for the fiscal year.